David Chain is currently the Director of Translational Proteomics at AstraZeneca, where they also hold the position of Associate Director leading AI Digital Imaging and Cell Enrichment in Oncology R&D. They previously served as a Research Investigator in Molecular Histology and Applied Imaging at Sanofi Genzyme from 2012 to 2018 and as a Scientist in Molecular Pathology at sanofi-aventis from 2000 to 2012. Chain's academic journey includes a Ph.D. in Nanomedicine and Clinical Informatics from Rutgers University, expected in 2024, and a Master of Science in Clinical Trial Sciences, with a perfect GPA, which they earned in 2015 from Rutgers University-New Brunswick. They also pursue a Bachelor of Pharmacy in Pharmaceutical Sciences at Rutgers University College of Pharmacy.
This person is not in any teams
This person is not in any offices